Lazard Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Buy
47,543
+5,059
+12% +$187K ﹤0.01% 1032
2025
Q4
$1.79M Buy
42,484
+3,856
+10% +$155K ﹤0.01% 918
2025
Q3
$1.33M Sell
38,628
-114,385
-75% -$3.28M ﹤0.01% 1036
2025
Q2
$4.13M Buy
153,013
+30,686
+25% +$889K 0.01% 786
2025
Q1
$3.63M Buy
122,327
+24,518
+25% +$935K 0.01% 784
2024
Q4
$3.87M Buy
97,809
+26,026
+36% +$985K 0.01% 700
2024
Q3
$2.44M Buy
71,783
+66,121
+1,168% +$1.86M ﹤0.01% 827
2024
Q2
$122K Sell
5,662
-706
-11% -$14.8K ﹤0.01% 1693
2024
Q1
$140K Buy
6,368
+3,271
+106% +$79.8K ﹤0.01% 1422
2023
Q4
$85K Sell
3,097
-4,248
-58% -$103K ﹤0.01% 1723
2023
Q3
$163K Buy
7,345
+3,775
+106% +$97.1K ﹤0.01% 1458
2023
Q2
$90K Hold
3,570
﹤0.01% 1621
2023
Q1
$79K Sell
3,570
-52,242
-94% -$1.26M ﹤0.01% 1622
2022
Q4
$1.32M Buy
55,812
+35,317
+172% +$821K ﹤0.01% 963
2022
Q3
$339K Buy
20,495
+16,149
+372% +$363K ﹤0.01% 1162
2022
Q2
$86K Buy
4,346
+936
+27% +$18.9K ﹤0.01% 1568
2022
Q1
$94K Buy
3,410
+1,079
+46% +$30.9K ﹤0.01% 1420
2021
Q4
$96K Buy
2,331
+896
+62% +$39.6K ﹤0.01% 1456
2021
Q3
$66K Buy
+1,435
New +$62.6K ﹤0.01% 1560
2021
Q2
Sell
-1,677
Closed -$90K 2086
2021
Q1
$90K Buy
1,677
+433
+35% +$24.9K ﹤0.01% 1228
2020
Q4
$60K Buy
+1,244
New +$57.6K ﹤0.01% 1326
2020
Q3
Sell
-3,534
Closed -$91K 1747
2020
Q2
$91K Buy
+3,534
New +$88K ﹤0.01% 1045
2020
Q1
Sell
-2,183
Closed -$60K 1768
2019
Q4
$60K Buy
2,183
+1,420
+186% +$36.8K ﹤0.01% 1020
2019
Q3
$18K Buy
+763
New +$20.3K ﹤0.01% 1107

Other funds holding VCYT

Lazard Asset Management's VCYT Position: Q1 2026 in Review

Lazard Asset Management increased its Veracyte (VCYT) stake by 12% in Q1 2026, buying an estimated $187K and bringing the position to 47,543 shares worth $1.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1032.

Lazard Asset Management first reported a position in VCYT in Q3 2019 and has held it in 24 quarters since. The position peaked at $4.13M in Q2 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Lazard Asset Management held 47,543 shares of Veracyte worth $1.53M as of Q1 2026.
  • Lazard Asset Management bought 5,059 Veracyte shares in Q1 2026, an estimated $187K.
  • Veracyte made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1032 holding.
  • Lazard Asset Management first reported a position in Veracyte in Q3 2019 and has held it in 24 quarters since.
  • Lazard Asset Management's Veracyte position peaked at $4.13M in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.